Dr Wanda Cui (MBBS BMedSci FRACP) is a consultant medical oncologist in the Breast Cancer and Lung Cancer Service at Peter MacCallum Cancer Centre, and a PhD candidate at the University of Melbourne. Her areas of interest are cancer and pregnancy, understanding and preventing the unwanted effects of cancer treatments on ovarian function and fertility, and cancer prevention.

After graduating from the University of Melbourne and completing her medical oncology specialist training in Melbourne, Dr Cui underwent a clinical fellowship at the Royal Marsden Hospital, London, where she later worked as a consultant medical oncologist in the Royal Marsden Lung Cancer Unit. She returned to Australia in 2022 and works in the breast cancer clinic, lung cancer clinic, and cancer risk management clinic at Peter MacCallum Cancer Centre.

Her research focuses on oncofertility and cancer prevention. She is the first author of the ASCO research statement regarding assessing ovarian toxicity in cancer clinical trials. She is a member of the prevention working group of the Lancet Breast Cancer Commission and is the Breast Cancer Trials Australia deputy chair for the Decrescendo trial.